Related Experiment Video
Updated: Mar 7, 2026

05:05
Establishing a Device for Sleep Deprivation in Mice
Published on: September 22, 2023
2.7K
CDKL5 deficiency entails sleep apneas in mice
Viviana Lo Martire1, Sara Alvente1, Stefano Bastianini1
1Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy.
Journal of Sleep Research
|February 24, 2017
Summary
Mice with a CDKL5 gene mutation (CDKL5-KO) experienced more frequent sleep apneas than normal mice (WT). This finding suggests sleep-disordered breathing is a key feature of CDKL5 disorder.
Area of Science:
- Neuroscience
- Genetics
- Respiratory Medicine
Background:
- Cyclin-dependent kinase-like 5 (CDKL5) disorder is a neurodevelopmental condition with autistic-like behaviors.
- Physiological impacts of CDKL5 disorder, particularly sleep-disordered breathing, are understudied, especially in adults.
- Sleep-disordered breathing is prevalent and serious in Rett syndrome, suggesting a potential link to CDKL5 disorder.
Purpose of the Study:
- To investigate differences in sleep breathing patterns between adult CDKL5 knockout (Cdkl5-KO) and wild-type (WT) mice.
- To determine if sleep apneas are more frequent in mice with CDKL5 deficiency.
- To explore the potential of sleep apnea occurrence as a biomarker for CDKL5 disorder.
Main Methods:
- Utilized whole-body plethysmography for non-invasive recording of sleep and breathing.
- Recorded physiological data for 8 hours during the light period in adult Cdkl5-KO and WT mice.
- Employed receiver operating characteristic (ROC) analysis to differentiate between genotypes based on breathing patterns.
Main Results:
- Sleep apneas occurred significantly more frequently in Cdkl5-KO mice compared to WT mice.
- ROC analysis successfully discriminated between Cdkl5-KO and WT mice based on sleep apnea occurrence.
- Sleep apnea frequency emerged as a significant differentiator between the two groups.
Conclusions:
- Sleep apneas are identified as a core feature of the CDKL5 disorder in a mouse model.
- Sleep-disordered breathing, specifically sleep apnea, can serve as a respiratory biomarker for CDKL5 deficiency.
- Routine evaluation of sleep-disordered breathing is recommended for patients with CDKL5 disorder.

